{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:36:54Z","timestamp":1753893414764,"version":"3.41.2"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p>The first-line treatment of severe aplastic anemia is allogeneic hematopoietic stem cell transplantation with a matched sibling donor. However, co-morbidities of the identical donor can make donation difficult. We present a transplantation where in parallel with the patient\u2019s conditioning treatment, the preparation of the donor with severe hemophilia A required a special management with perioperative factor VIII substitution. Donation was successful without complications, and 18\u00a0months after transplantation, the patient and his donor are well without any long-term sequelae. To our knowledge, this is the first reported succesfull transplantation with hemophilic child serving as a bone marrow donor. The procedure did not mean a significant risk to donor health, so donors with hemophilia should not be excluded from donation.<\/jats:p>","DOI":"10.3389\/pore.2022.1610171","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T10:42:21Z","timestamp":1654684941000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A Child With Hemophilia A Serves as Donor for Hematopoietic Stem Cell Transplantation to Cure His Brother\u2019s Severe Aplastic Anemia"],"prefix":"10.3389","volume":"28","author":[{"given":"Gabriella","family":"Kert\u00e9sz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriszti\u00e1n","family":"K\u00e1llay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Zombori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Bod\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csongor","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely","family":"Kriv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.17235\/reed.2018.5204\/2017","article-title":"Liver Transplantation in Hemophilia A and Von Willebrand Disease Type 3: Perioperative Management and Post-Transplant Outcome","volume":"110","author":"Alonso Madrigal","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"key":"B2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1365-2516.2008.01950.x","article-title":"Replacement Therapy for Invasive Procedures in Patients with Haemophilia: Literature Review, European Survey and Recommendations","volume":"15","author":"Hermans","year":"2009","journal-title":"Haemophilia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1053\/j.jvca.2020.06.074","article-title":"Perioperative Management of Hemophilia A Patients Undergoing Cardiac Surgery: A Literature Review of Published Cases","volume":"35","author":"Lin","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2141.2012.09089.x","article-title":"How to Manage Invasive Procedures in Children with Haemophilia","volume":"157","author":"Ljung","year":"2012","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk Factors for Inhibitor Development in Severe Hemophilia a","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jth.13888","article-title":"Timing and Severity of Inhibitor Development in Recombinant versus Plasma-Derived Factor VIII Concentrates: A SIPPET Analysis","volume":"16","author":"Peyvandi","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/nejmoa1208024","article-title":"Factor VIII Products and Inhibitor Development in Severe Hemophilia A","volume":"368","author":"Gouw","year":"2013","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/bf02592576","article-title":"Orthotopic Liver Transplantation in a Patient with Severe Hemophilia A: A Life-Saving Treatment for the First Italian Case","volume":"25","author":"Federici","year":"1995","journal-title":"Int J Clin Lab Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A Conditional Knockout Mouse Model Reveals Endothelial Cells as the Principal and Possibly Exclusive Source of Plasma Factor VIII","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e77255","DOI":"10.1371\/journal.pone.0077255","article-title":"Production of Factor VIII by Human Liver Sinusoidal Endothelial Cells Transplanted in Immunodeficient uPA Mice","volume":"8","author":"Fomin","year":"2013","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood-2014-05-568857","article-title":"In Search of the Source of Factor VIII","volume":"123","author":"Tuddenham","year":"2014","journal-title":"Blood"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T10:42:23Z","timestamp":1654684943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2022.1610171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":11,"alternative-id":["10.3389\/pore.2022.1610171"],"URL":"https:\/\/doi.org\/10.3389\/pore.2022.1610171","relation":{},"ISSN":["1532-2807"],"issn-type":[{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"article-number":"1610171"}}